
CAR T Cells Immunotherapy: A Breakthrough in Advanced Cancer Treatments
CAR T cells immunotherapy has emerged as a transformative approach in the fight against advanced cancers. This innovative treatment leverages the body’s immune system, specifically T cells, which are modified to better target and destroy cancer cells. The process begins with the extraction of T cells from the patient’s blood. These cells are then genetically altered in a laboratory to express chimeric antigen receptors (CARs) on their surface. Once reintroduced into the patient’s body, these engineered cells can recognize and attack cancer cells with precision. The therapy has shown exceptional promise in treating certain blood cancers, such as leukemia and lymphoma, where traditional treatments have often fallen short. How CAR T Cells Immunotherapy Works The mechanism of CAR T cells immunotherapy involves several critical steps. First, T cells are collected from the patient through a process called leukapheresis. These cells are then sent to a specialized facility where they are genetically modified to produce CARs. The CARs enable the T cells to identify specific proteins on the surface of cancer cells. After being multiplied in the lab, the enhanced T cells are infused back into the patient. Once inside the body, they proliferate and launch a targeted attack against the cancer cells.